The immunobiology of apotransferrin in type 1 diabetes

Clinical and Experimental Immunology, 05/25/2012

The authors confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long–lasting disease. The data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.

Print Article Summary Cat 2 CME Report